Area riservata



Istopatologia del cuore: febbre reumatica

Reumatologia
Drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing
Scritto da Annals of the Rheumatic Diseases current issue   
Reumatologia

I read with interest the meta-analysis by Roubille et al,1 especially for the adverse effects noted with glucocorticoids (GCs). The data appear to confirm the risk of GC, which is surprising ... ...

 
Response to: 'Drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing ' by Dr Boers
Scritto da Annals of the Rheumatic Diseases current issue   
Reumatologia

We thank Dr Boers for the interesting comments1 on our paper2. First, the decision to exclude studies reporting less than 400 patients was made afte ... ...

 
Does MOVES move the needle
Scritto da Annals of the Rheumatic Diseases current issue   
Reumatologia

Osteoarthritis (OA) of the knee is a common and vexing condition. Additional safe and effective modalities to treat this chronic condition are badly needed.

The article by Hochberg et al1... continua Aggiungi commento

 
Response to: 'Does MOVES move the needle ' by Dr Meyer
Scritto da Annals of the Rheumatic Diseases current issue   
Reumatologia

We thank Dr Meyer1 for his comments on the Glucosamine/chondroitin Arthritis Intervention Trial (GAIT)2 and the Multicentre Osteoarthritis interVEnt ... ...

 
Is chondroitin sulfate plus glucosamine superior to placebo in the treatment of knee osteoarthritis
Scritto da Annals of the Rheumatic Diseases current issue   
Reumatologia

We read with interest the article by Hochberg et al1 related to the efficacy and safety of chondroitin sulfate plus glucosamine hydrochloride (CS+GH) versus celecoxib in patients with knee o ... ...

 
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close
Scritto da Annals of the Rheumatic Diseases current issue   
Reumatologia

It is widely accepted in the rheumatology community that a ‘therapeutic window of opportunity’ exists for patients with rheumatoid arthritis (RA), that the disease is much more amenable to treatment within this window, and that treatm ... ...

 
Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle di
Scritto da Annals of the Rheumatic Diseases current issue   
Reumatologia

Primary cardiac involvement, an under-recognised manifestation of the idiopathic inflammatory myopathies (IIM) and systemic sclerosis (SSc)-spectrum disorders, is associated with significant mortality. Within these two conditions, traditional ske ... ...

 
<< Inizio < Prec. 1 2 3 4 5 6 7 8 9 10 Succ. > Fine >>

Pag 1 di 689